Sai Nath University, Ranchi, Jharkhand-835219, India
Dysmenorrhea, characterized by painful menstrual cramps, affects a significant proportion of reproductive-aged women worldwide, with primary dysmenorrhea being the most prevalent form. This comprehensive review examines the multifaceted nature of dysmenorrhea, exploring its underlying pathophysiological mechanisms, clinical presentations, and evidence-based treatment approaches. Primary dysmenorrhea involves complex interactions between prostaglandins, inflammatory mediators, and uterine contractility, while secondary dysmenorrhea stems from underlying pelvic pathology. The review synthesizes current understanding of hormonal influences, genetic factors, and psychosocial components that contribute to pain severity and treatment response. Treatment modalities range from pharmacological interventions including nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, and complementary therapies to lifestyle modifications and psychological support. This review provides healthcare providers and caregivers with evidence-based insights to optimize patient care, emphasizing the importance of individualized treatment approaches and comprehensive pain management strategies. Understanding the complexity of dysmenorrhea enables better patient outcomes through informed clinical decision-making and patient education.
Dysmenorrhea represents one of the most common gynecological complaints affecting women of reproductive age, with prevalence rates ranging from 45% to 95% globally [Ahmed et al., 2019; Bernardi et al., 2017]. The condition is broadly classified into primary and secondary forms, each presenting distinct etiological factors and therapeutic considerations. Primary dysmenorrhea occurs in the absence of identifiable pelvic pathology and typically manifests during adolescence following the establishment of ovulatory cycles [Dawood, 2006; French, 2005]. Secondary dysmenorrhea, conversely, results from underlying gynecological conditions such as endometriosis, uterine fibroids, or pelvic inflammatory disease, often developing later in reproductive life [Iacovides et al., 2015; Proctor & Farquhar, 2006]. The clinical significance of dysmenorrhea extends beyond the immediate physical discomfort, substantially impacting quality of life, academic performance, work productivity, and psychological well-being [Armour et al., 2019; Ju et al., 2014]. Studies indicate that severe dysmenorrhea contributes to significant school and work absenteeism, with economic implications for both individuals and healthcare systems. Despite its prevalence and impact, dysmenorrhea remains underdiagnosed and undertreated in many healthcare settings, highlighting the need for comprehensive understanding among healthcare providers and caregivers [Burnett et al., 2005; Parker et al., 2010]. The pathophysiology of dysmenorrhea involves complex interactions between hormonal fluctuations, inflammatory mediators, and neurological pain pathways. Recent advances in understanding these mechanisms have led to more targeted therapeutic approaches, yet challenges remain in achieving optimal pain management for all patients [Harel, 2006; Marjoribanks et al., 2010]. This review aims to provide a comprehensive examination of current knowledge regarding dysmenorrhea mechanisms and evidence-based treatment strategies to guide clinical practice and improve patient outcomes.
Ankita Singh, Rashmi Kumari, Smita Bharti, Neha Kumari, Sweta Kumari, Annu Priya, Luckey Kumari, Sneha Singh, Mona Singh, Anushreya Soreng, Pinki Kumari, Archna Kumari, Dibya Kumari, Priyanka Kumari, Sneha Sinha, Jasmine Kumari, Chhaya Kumari, Pushpa Kumari, Arnab Roy*, Unravelling the Complexity of Dysmenorrhea: A Review of the Underlying Mechanisms and Treatment Options for Caregivers and Patients, Int. J. Sci. R. Tech., 2025, 2 (10), 245-252. https://doi.org/10.5281/zenodo.17339137
10.5281/zenodo.17339137
